Ovarian Cancer Screening in Basavanagudi, Jayanagar, JP Nagar
HOME | HEALTH PACKAGES | Ovarian Cancer Screening
- HEALTH PACKAGES
Top Rated Ovarian Cancer Screening Available
Tests that may be useful for women at high risk of ovarian cancer include a blood test of the CA 125 tumor marker, ultrasound, or a combination of the two.
CA 125 tumor marker — CA 125 is a protein that is higher than normal in approximately 80 percent of women with ovarian cancer. It can be measured with a blood test. CA 125 is commonly used to monitor women with ovarian cancer.
It was hoped that CA 125 could be used to know if a woman was at risk for ovarian cancer. However, CA 125 levels can be high with a variety of other conditions, including:
Benefits of choosing Dr Diagnostics
Smart Reports In 30 Mins
Free Reports Consultation
Most Affordable Pricing
On-time Sample Collection
- GENERAL QUESTIONS
Frequently asked questions.
Ans: Despite years of research, experts haven’t yet developed a successful ovarian cancer screening test. For this reason, the condition is often difficult to diagnose in the early stages.
If your healthcare provider suspects ovarian cancer, they’ll ask about your symptoms and perform a pelvic exam. During the exam, they’ll check for any abnormal growths or enlarged organs.
Ans: Some results might be available very quickly, such as a full blood count and kidney and liver function tests. Other tests might take several weeks.
Ans: The blood test CA125 can be used to help diagnose or exclude ovarian cancer. CA125 is a protein found in the blood and can be produced by ovarian cancer cells. However, there are other causes for raised CA125 levels such as menstruation, endometriosis or ovarian.
Ans:
Ovarian cancer is often diagnosed at an advanced stage. Unfortunately, this is because early-stage ovarian cancer typically doesn’t cause noticeable symptoms, or if it does, they may be subtle and easily attributed to other less serious conditions. As a result, ovarian cancer is often not detected until it has progressed to an advanced stage and spread beyond the ovaries.
According to the American Cancer Society, only about 20% of ovarian cancers are found at an early stage. The majority of cases are diagnosed at later stages when the cancer has already spread to the pelvis or abdomen, making treatment more challenging.
Regular pelvic exams, along with other screening tests such as transvaginal ultrasound and the CA-125 blood test, may help detect ovarian cancer at an earlier stage in some cases. However, these screening methods are not foolproof and are not recommended for the general population due to limitations in their accuracy and potential for false positives.